Estimated 92 million Americans who suffer from CRD/CVD
may require continuous RHR + RR monitoring from home.
Continuously, Consistently, Accurately, Reliably and Automatically monitor motion (actigraphy), resting heart rate and breathing rate through out day and night while simply being at home.
There are an estimated 92 million Americans that suffer from a form of CRD (Chronic Respiratory Disease) or CVD (Cardiovascular Disease). Some 15 million of them are seniors. Continuous monitoring of RHR + RR may provide important information in their treatment and also give early deterioration detection alerts.
As of May 21, 2021, there were almost 166 million global cases of COVID-19. Around 147 million people had recovered from the disease, of which 27.5M are American.
Xandar Kardian’s XK300 sensor is able to detect vital signs 10 times per second giving 600 results per minute. During one 8 hour overnight period, if the user was “still” for 5 hours (out of 8 hours), we can estimate that 18,000 seconds of vital sign data was collected. Daily recording of motion, RHR and RR can provide critical insight to the residents overall health & wellbeing.
Users also have the option of assigning “caretakers” who can be friends, neighbors or family. Caretakers are given access to the users vital signs, including potential alerts for adverse events.
Xandar Kardian XK300 is FDA 510(k) cleared to use as a home healthcare sensor for data collection to inform patient care. Certain users who have Medicaid/Medicare suffering from chronic respiratory diseases and CVDs can quality for Medicare/Medicaid reimbursement under CPT CODE 99454, 99457 and 99458.